The clathrin adaptor complex-1 and Rab12 regulate post-golgi trafficking of WT epidermal growth factor receptor...

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Epidermal growth factor receptor (EGFR) is vital for cancer progression and a key target in cancer therapy.
• The precise mechanisms governing the cell surface delivery of newly synthesized EGFR are not fully understood.

Purpose of the Study:

• To investigate the molecular mechanisms controlling the transport of EGFR from the trans-Golgi network (TGN) to the cell surface.
• To identify proteins involved in EGFR trafficking and their role in EGFR signaling.

Main Methods:

• Gene knockout and siRNA knockdown techniques were employed.
• Biochemical assays including streptavidin pull-down and co-immunoprecipitation were utilized.
• Analysis of EGFR phosphorylation, cell elongation, and proliferation was performed.

Main Results:

• The clathrin adaptor complex-1 (AP-1) and Rab12 were identified as interacting partners of EGFR, regulating its export from the TGN.
• A specific tyrosine residue (Y998) on EGFR is critical for AP-1 binding and TGN export.
• AP-1 and Rab12 are essential for epidermal growth factor-induced EGFR phosphorylation, cell elongation, and proliferation.
• Export of the constitutively active mutant EGFR^L858R from the TGN is independent of AP-1 and Rab12.

Conclusions:

• AP-1 and Rab12 mediate post-Golgi trafficking essential for wild-type EGFR signaling.
• The TGN export pathways for wild-type EGFR and the mutant EGFR^L858R differ, highlighting distinct regulatory mechanisms.